These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31256854)

  • 1. Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias.
    Mangaonkar AA; Ferrer A; Pinto E Vairo F; Cousin MA; Kuisle RJ; Gangat N; Hogan WJ; Litzow MR; McAllister TM; Klee EW; Lazaridis KN; Stewart AK; Patnaik MM
    Mayo Clin Proc; 2019 Sep; 94(9):1753-1768. PubMed ID: 31256854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).
    Steensma DP
    Curr Hematol Malig Rep; 2019 Dec; 14(6):536-542. PubMed ID: 31696381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
    Gill S; Carney D; Ritchie D; Wolf M; Westerman D; Prince HM; Januszewicz H; Seymour JF
    Ann Oncol; 2010 Feb; 21(2):331-334. PubMed ID: 19625344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.
    Newman K; Owlia MB; El-Hemaidi I; Akhtari M
    Autoimmun Rev; 2013 May; 12(7):784-91. PubMed ID: 23462431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes.
    Blombery P; Fox L; Ryland GL; Thompson ER; Lickiss J; McBean M; Yerneni S; Hughes D; Greenway A; Mechinaud F; Wood EM; Lieschke GJ; Szer J; Barbaro P; Roy J; Wight J; Lynch E; Martyn M; Gaff C; Ritchie D
    Haematologica; 2021 Jan; 106(1):64-73. PubMed ID: 32054657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
    Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
    Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.
    Gilad O; Dgany O; Noy-Lotan S; Krasnov T; Yacobovich J; Rabinowicz R; Goldberg T; Kuperman AA; Abu-Quider A; Miskin H; Kapelushnik N; Mandel-Shorer N; Shimony S; Harlev D; Ben-Ami T; Adam E; Levin C; Aviner S; Elhasid R; Berger-Achituv S; Chaitman-Yerushalmi L; Kodman Y; Oniashvilli N; Hameiri-Grosman M; Izraeli S; Tamary H; Steinberg-Shemer O
    Haematologica; 2022 Sep; 107(9):2081-2095. PubMed ID: 35295078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry.
    Català A; Ali SS; Cuvelier GDE; Steele M; Klaassen RJ; Fernandez CV; Pastore YD; Abish S; Rayar M; Jardine L; Breakey VR; Brossard J; Sinha R; Silva M; Goodyear L; Lipton JH; Michon B; Corriveau-Bourque C; Sung L; Lauhasurayotin S; Zlateska B; Cada M; Dror Y
    Br J Haematol; 2020 Jun; 189(5):976-981. PubMed ID: 32128787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic emergencies in the pediatric emergency room.
    Sadowitz PD; Amanullah S; Souid AK
    Emerg Med Clin North Am; 2002 Feb; 20(1):177-98, vii. PubMed ID: 11826633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital cytopenias and bone marrow failure syndromes.
    Rivers A; Slayton WB
    Semin Perinatol; 2009 Feb; 33(1):20-8. PubMed ID: 19167578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal manifestations of inherited bone marrow failure syndromes.
    Khincha PP; Savage SA
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):57-65. PubMed ID: 26724991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.
    Michniacki TF; Ebens CL; Choi SW
    Curr Oncol Rep; 2019 Aug; 21(10):87. PubMed ID: 31414187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
    Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children.
    Kim TO; Despotovic JM
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):489-506. PubMed ID: 31030815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow failure].
    Drexler B; Tichelli A; Passweg JR
    Ther Umsch; 2019; 76(9):523-529. PubMed ID: 32157970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocupremia associated cytopenia and myelopathy: a national retrospective review.
    Gabreyes AA; Abbasi HN; Forbes KP; McQuaker G; Duncan A; Morrison I
    Eur J Haematol; 2013 Jan; 90(1):1-9. PubMed ID: 23034053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
    Bryce AH; Egan JB; Borad MJ; Stewart AK; Nowakowski GS; Chanan-Khan A; Patnaik MM; Ansell SM; Banck MS; Robinson SI; Mansfield AS; Klee EW; Oliver GR; McCormick JB; Huneke NE; Tagtow CM; Jenkins RB; Rumilla KM; Kerr SE; Kocher JA; Beck SA; Fernandez-Zapico ME; Farrugia G; Lazaridis KN; McWilliams RR
    Oncotarget; 2017 Apr; 8(16):27145-27154. PubMed ID: 28423702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic challenges of clonal cytopenia of undetermined significance.
    Weinberg OK
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():82-85. PubMed ID: 34288451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
    Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
    Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.